|
| | Intervention group | |
| All value (range) | Bariatric surgery therapy group value (range) | Conventional medication therapy group value (range) | Source |
|
| Cost (¥) |
| Initial cost | | 46,404.41 (37,123.28-55,684.92) | 12,581.46 (10,065.17-15,097.75) | The costs of the bariatric surgery therapy group were taken from the follow-up data; the costs of the conventional medication therapy group were derived from the basic medical insurance database of Nanjing employees |
| Incremental cost | | 2,766.41 (2,213.13-3,319.69) | 7,674.24 (6,139.39-9,209.09) |
| Utility weight reflecting |
| With type 2 diabetes | 0.77 (0.62-0.92) | | | Refer to [24] |
| Type 2 diabetes remission | 0.95 (0.76-1.00) | | | Refer to [25] |
| Transition probabilities |
| Annual probability for relapse to type 2 diabetes | 0.0025 (0.0020-0.0031) | | | Refer to [11], National Bureau of Statistics of China |
| Annual mortality probability: type 2 diabetes (age 42–82 years) | 0.0204 (0.0163-0.0245) | | | Refer to [11, 19, 21, and 22] |
| Annual mortality probability: type 2 diabetes remission (age 42–82 years) | 0.0062 (0.0050-0.0074) | | | Refer to [11, 19, 21, and 22] |
| Rate (%) |
| Rate | 5 (4-6) | | | |
|
